Medifast, Inc. (MED)
12.00
+0.05
(+0.42%)
USD |
NYSE |
Aug 24, 16:00
12.02
+0.02
(+0.12%)
Pre-Market: 20:00
Medifast Shareholders Equity (Quarterly) : 196.38M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 196.38M |
| March 31, 2026 | 197.68M |
| December 31, 2025 | 198.92M |
| September 30, 2025 | 214.71M |
| June 30, 2025 | 216.00M |
| March 31, 2025 | 210.96M |
| December 31, 2024 | 210.11M |
| September 30, 2024 | 207.34M |
| June 30, 2024 | 205.28M |
| March 31, 2024 | 210.96M |
| December 31, 2023 | 201.48M |
| September 30, 2023 | 193.04M |
| June 30, 2023 | 185.56M |
| March 31, 2023 | 170.90M |
| December 31, 2022 | 155.04M |
| September 30, 2022 | 150.52M |
| June 30, 2022 | 129.48M |
| March 31, 2022 | 216.02M |
| December 31, 2021 | 202.47M |
| September 30, 2021 | 196.24M |
| June 30, 2021 | 194.69M |
| March 31, 2021 | 174.89M |
| December 31, 2020 | 157.25M |
| September 30, 2020 | 140.01M |
| June 30, 2020 | 116.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 110.75M |
| December 31, 2019 | 104.83M |
| September 30, 2019 | 111.20M |
| June 30, 2019 | 126.02M |
| March 31, 2019 | 122.07M |
| December 31, 2018 | 109.11M |
| September 30, 2018 | 111.64M |
| June 30, 2018 | 102.86M |
| March 31, 2018 | 113.63M |
| December 31, 2017 | 108.58M |
| September 30, 2017 | 108.21M |
| June 30, 2017 | 104.18M |
| March 31, 2017 | 99.17M |
| December 31, 2016 | 96.02M |
| September 30, 2016 | 94.93M |
| June 30, 2016 | 91.26M |
| March 31, 2016 | 89.86M |
| December 31, 2015 | 88.58M |
| September 30, 2015 | 86.81M |
| June 30, 2015 | 88.20M |
| March 31, 2015 | 84.83M |
| December 31, 2014 | 80.48M |
| September 30, 2014 | 82.55M |
| June 30, 2014 | 97.51M |
| March 31, 2014 | 105.17M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| United Natural Foods, Inc. | 1.598B |
| Integrated BioPharma, Inc. | 18.98M |
| BioForce Nanosciences Holdings, Inc. | 2.303M |
| Skinvisible, Inc. | -10.79M |
| Nevis Brands, Inc. | 0.6951M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 260.40M |
| Total Liabilities (Quarterly) | 64.02M |
| Debt to Equity Ratio | 0.1406 |
| Current Ratio | 4.861 |
| Net Debt Paydown Yield | -2.19% |